BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Manzhalii E, Moyseyenko V, Kondratiuk V, Molochek N, Falalyeyeva T, Kobyliak N. Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment. World J Hepatol 2022; 14(3): 634-646 [PMID: 35582294 DOI: 10.4254/wjh.v14.i3.634]
URL: https://www.wjgnet.com/1948-5182/full/v14/i3/634.htm
Number Citing Articles
1
Frances Widjaja, Ivonne M. C. M. Rietjens. From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research PurposesBiomedicines 2023; 11(10): 2658 doi: 10.3390/biomedicines11102658
2
Rachel Redfield, Nyan Latt, Santiago J. Munoz. Minimal Hepatic EncephalopathyClinics in Liver Disease 2024; 28(2): 237 doi: 10.1016/j.cld.2024.01.004
3
Ming Luo, Rui-Juan Xin, Fang-Rui Hu, Li Yao, Sheng-Juan Hu, Fei-Hu Bai. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy <i>via </i>the gut-liver-brain axisWorld Journal of Gastroenterology 2023; 29(1): 144-156 doi: 10.3748/wjg.v29.i1.144
4
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Nazarii Kobyliak. Microbiome in 3P Medicine StrategiesAdvances in Predictive, Preventive and Personalised Medicine 2023; 16: 275 doi: 10.1007/978-3-031-19564-8_10
5
Garima Mishra, Pradeep Singh, Mulugeta Molla, Yohannes Shumet Yimer, Subas Chandra Dinda, Phool Chandra, Bhuvnesh Kumar Singh, Samuel Berihun Dagnew, Abraham Nigussie Assefa, Amien Ewunetie. Harnessing the potential of probiotics in the treatment of alcoholic liver disordersFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1212742
6
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosisCochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
7
Luca Falzone, Alessandro Lavoro, Saverio Candido, Mario Salmeri, Antonino Zanghì, Massimo Libra. Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2397874
8
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Oksana Sulaieva, Tetyana Falalyeyeva, Nazarii Kobyliak. Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trialFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.994911
9
Cynthia L. Hsu, Bernd Schnabl. The gut–liver axis and gut microbiota in health and liver diseaseNature Reviews Microbiology 2023; 21(11): 719 doi: 10.1038/s41579-023-00904-3
10
Jie Gao, Rui Nie, Hong Chang, Wei Yang, Qian Ren. A meta-analysis of microbiome therapies for hepatic encephalopathyEuropean Journal of Gastroenterology & Hepatology 2023; 35(9): 927 doi: 10.1097/MEG.0000000000002596
11
Fan Xue, Zheng He, De-Zheng Zhuang, Feng Lin. The influence of gut microbiota on circulating inflammatory cytokines and host: A Mendelian randomization study with meta-analysisLife Sciences 2023; 332: 122105 doi: 10.1016/j.lfs.2023.122105
12
Ming Yang, Katina Massad, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li. Gut microbiota and metabolite interface-mediated hepatic inflammationImmunometabolism 2024; 6(1): e00037 doi: 10.1097/IN9.0000000000000037
13
Xing Yang, Langhuan Lei, Wei Shi, Xiaozhen Li, Xiaozhi Huang, Liuyan Lan, Jiali Lin, Qiuyu Liang, Wei Li, Jianrong Yang. Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trialsFrontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1379333
14
Kiran Heer, Manpreet Kaur, Dwinder Sidhu, Priyankar Dey, Saumya Raychaudhuri. Modulation of gut microbiome in response to the combination of Escherichia coli Nissle 1917 and sugars: a pilot study using host-free system reflecting impact on interpersonal microbiomeFrontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1452784
15
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiotaWorld Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
16
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver AxisGastrointestinal Disorders 2024; 6(1): 64 doi: 10.3390/gidisord6010005
17
Tao Yang, Qijie Guan, Jin-Song Shi, Zheng-Hong Xu, Yan Geng. Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiotaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(5): 166664 doi: 10.1016/j.bbadis.2023.166664
18
Fernanda Raya Tonetti, Alvaro Eguileor, Marko Mrdjen, Vai Pathak, Jared Travers, Laura E. Nagy, Cristina Llorente. Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver diseaseHepatology 2024; 80(6): 1342 doi: 10.1097/HEP.0000000000000924